Recombinant Human CREG1 Protein，His

CREG1 (Cellular Repressor of E1A Stimulated Genes 1) is a protein that has garnered significant interest in biomedical research due to its role in various cellular processes, including cell proliferation, differentiation, and response to stress. Initially identified as a regulator of cellular growth influenced by the E1A protein, CREG1 has been implicated in numerous pathological conditions, including cancer and cardiovascular diseases. Its expression is often dysregulated in tumor tissues, suggesting a potential role in tumorigenesis and metastasis. Furthermore, recent studies have highlighted CREG1's involvement in modulating inflammation and tissue repair, positioning it as a critical factor in regenerative medicine. The exploration of CREG1 as a recombinant protein holds promise for elucidating its functional mechanisms and therapeutic potential. Researchers are investigating its structure-function relationships, signaling pathways, and interactions with other proteins, aiming to harness its properties for novel clinical applications. Advances in recombinant protein technology have enabled the production of CREG1 in heterologous systems, facilitating detailed functional assays and drug development. Understanding the biological implications of CREG1 through recombinant protein studies could pave the way for innovative strategies in cancer therapy, regenerative medicine, and inflammatory diseases, maximizing its translational potential in clinical settings.